Status:
COMPLETED
Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Breast Cancer
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
RATIONALE: Measuring levels of transforming growth factor-beta (TGF-beta) in the blood of patients with epithelial cancers (head and neck, lung, breast, colorectal, and prostate) may help doctors pred...
Detailed Description
OBJECTIVES: * To determine whether there is a dose-dependent increase in TGF-beta following radiotherapy in patients with epithelial cancers. OUTLINE: Patients undergo blood sample collection prior ...
Eligibility Criteria
Inclusion
- DISEASE CHARACTERISTICS:
- Known diagnosis of an epithelial cancer, including any of the following:
- Head and neck
- Lung
- Breast
- Colorectal
- Prostate
- Radiotherapy must be a component of planned treatment therapy
- PATIENT CHARACTERISTICS:
- No serious medical or psychiatric illnesses which would prevent informed consent
Exclusion
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00897793
Start Date
January 1 2006
End Date
July 1 2010
Last Update
April 12 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Vanderbilt-Ingram Cancer Center - Cool Springs
Nashville, Tennessee, United States, 37064
2
Vanderbilt-Ingram Cancer Center at Franklin
Nashville, Tennessee, United States, 37064
3
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, United States, 37232-6838